| Financial Year |
March 31 2023 |
| Monetary Funds |
4,221,928,406.47 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
690,471,909.85 |
| Accounts Receivable |
3,108,594,710.41 |
| Advances to Suppliers |
239,764,521.52 |
| Other Receivables |
50,213,695.42 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,274,938,719.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
49,130,254.46 |
| Total Current Assets |
9,687,292,525.48 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,944,327,552.78 |
| Under-construction Projects |
585,878,920.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
607,147,165.88 |
| R&D expenses |
2,602,702.51 |
| Goodwill |
15,514,588.54 |
| Long-Term Deferred and Prepaid Expenses |
4,211,763.08 |
| Deferred Income Tax Assets |
253,116,681.42 |
| Other Non-Current Assets |
112,883,637.60 |
| Sub-Total of Non-Current Assets |
5,546,300,787.80 |
| Total Assets |
15,233,593,313.28 |
| Short-Term Loans |
552,323,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,056,059,080.76 |
| Accounts Payable |
2,226,843,028.51 |
| Accounts Received In Advance |
12,991,760.77 |
| Employee Compensation Payable |
567,817,749.61 |
| Taxes Payable |
216,045,642.60 |
| Interest Payable |
587,691.16 |
| Dividend Payable |
-- |
| Other payables |
438,335,026.71 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
7,824,092.89 |
| Other Current Liabilities |
43,911,357.34 |
| Sub-Total of Current Liabilities |
5,441,411,516.37 |
| Long-term Loans |
253,181,519.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
248,067.84 |
| Special Payable |
-- |
| Estimatied Liabilities |
185,050,000.00 |
| Deferred Income Tax Liabilities |
10,644,959.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
494,513,551.93 |
| Total Liabilities |
5,935,925,068.30 |
| Paid-In Capital(Or Share Stock) |
309,898,907.00 |
| Capital Surplus |
591,546,619.08 |
| Surplus Reserve |
361,415,549.80 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
7,922,113,865.13 |
| Minority Stockholder's Interest |
4,746,277.61 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,292,921,967.37 |
| Owner's Equity（Stockholder's Equity） |
9,297,668,244.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
15,233,593,313.28 |
